GrayJAM.Evidence-based healthcare: the 21st-century agenda. MRC News1998; 34–37.
2.
BrownPRauEHJohnsonBKBacoteAEGibbsCJJr.GajdusekDC. New studies on the heat resistance of hamster-adapted scrapie agent: threshold survival after ashing at 600 degrees C suggests an inorganic template of replication. Proc Natl Acad Sci USA2000; 97:3418–21.
3.
BrownPPreeceMBrandelJPIatrogenic Creutzfeldt-Jakob disease at the millennium. Neurology2000; 55:1075–81.
4.
CuillJChellePL.La tremblante du mouton est bien inoculable. CR Acad Sci1938; 206:78–9.
5.
PrusinerSB.Novel proteinaceous infectious particles cause scrapie. Science1982; 216:136–44.
6.
HsiaoKBakerHFCrowTJLinkage of a prion protein missense variant to Gerstmann-Str ussier syndrome. Nature1989; 338:342–5.
7.
BrownPGibbsCJJr.Rodgers-JohnsonPHuman spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol1994; 35:513–29.
8.
SpencerMDKnightRSGWillRG.First hundred cases of variantCreutzfeldt-Jakob disease: retrospective case note review of early psychiatric and neurological features. BMJ2002; 324:1479–82.
9.
LorainsJWHenryCAgbamuDAVariant Creutzfeldt-Jakob disease in an elderly patient. Lancet2001; 357:1339–40.
10.
MacleodMAStewartGEZeidlerMWillRKnightR.Sensory features of variant Creutzfeldt-Jakob disease. J Neurol2002; 249:706–11.
11.
ZerrIPocchiariMCollinsSAnalysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease. Neurology2000; 55:811–15.
12.
GreenAJEThompsonEJStewartGEUse of 14-3-3 and other brain-specific proteins in the CSF in the diagnosis of variant Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry2001; 70:744–48.
13.
SchrterAZerrIHenkelKTschampaHJFinkenstaedtMPoserS.Magnetic resonance imaging in the clinical diagnosis of Creutzfeldt Jakob disease. Arch Neurol2000; 57:1751–57.
14.
CollieDASellarRJZeidlerMColchesterACFKnightRWillRG.MRI in Creutzfeldt-Jakob disease: imaging features and recommended MRI protocol. Clin Radiol2001; 56:726–39.
15.
World Health Organization. Report of the WHO consultation on the global surveillance, diagnosis and therapy of human transmissible spongiform encephalopathies. Geneva: WHO; 1998.
16.
World Health Organization, Report of a WHO Consultation on the revision of the variant CJD case definition. Geneva: WHO; 2001.
17.
HillAFButterworthRJJoinerSInvestigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet1999; 353:183–89.
18.
KorthCMayBCCohenFEPrusinerSB.Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease. Proc Natl Acad Sci U S A2001; 98:9836–41.